Mostrar el registro sencillo del ítem

dc.creatorEfthymiou G., Dardiotis E., Liaskos C., Marou E., Scheper T., Meyer W., Daponte A., Daoussis D., Hadjigeorgiou G., Bogdanos D.P., Sakkas L.I.en
dc.date.accessioned2023-01-31T07:37:07Z
dc.date.available2023-01-31T07:37:07Z
dc.date.issued2019
dc.identifier10.1016/j.clim.2019.07.012
dc.identifier.issn15216616
dc.identifier.urihttp://hdl.handle.net/11615/71280
dc.description.abstractAnti-human cytomegalovirus (HCMV) antibodies are considered triggers of systemic sclerosis (SSc), but such a hypothesis has been assessed in limited sub-dominant epitopes. Our aim was to systematically assess the potential association of HCMV antibodies targeting most immunodominant and subdominant viral antigens, as this would reveal immunopathogenic associations. Our study included 110 SSc patients, 60 multiple sclerosis (MS) patients, and 51 healthy controls (HC). Anti-HCMV abs were tested by immunoblotting. IgG anti-HCMV was broader in SSc and MS compared to HC. Anti- UL57 and UL55 were more frequent in SSc versus MS forms. Reactivity to multiple viral antigens was more frequent in SSc than MS forms. Anti-viral antibodies levels were higher in specific autoantibody-positive SSc patients compared to seronegative cases. In conclusion, more prevalent and/or stronger antigen-specific HCMV responses are noted in SSc compared to controls, implying a role of these viral responses in SSc development. © 2019 Elsevier Inc.en
dc.language.isoenen
dc.sourceClinical Immunologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85070634625&doi=10.1016%2fj.clim.2019.07.012&partnerID=40&md5=a3716ad86810ed61081a39db08ed502a
dc.subjectantinuclear antibodyen
dc.subjectautoantibodyen
dc.subjectazathioprineen
dc.subjectbeta1a interferonen
dc.subjectCytomegalovirus antibodyen
dc.subjectDNA directed RNA polymerase IIIen
dc.subjectfingolimoden
dc.subjectglatirameren
dc.subjectimmunoglobulin Gen
dc.subjectinterferon beta serineen
dc.subjectmethotrexateen
dc.subjectmitoxantroneen
dc.subjectnatalizumaben
dc.subjectp38 antigenen
dc.subjectsteroiden
dc.subjectteriflunomideen
dc.subjectul44 antigenen
dc.subjectul55 antigenen
dc.subjectul57 antigenen
dc.subjectul83 antigenen
dc.subjectul99 antigenen
dc.subjectunclassified drugen
dc.subjectvirus antigenen
dc.subjectepitopeen
dc.subjectimmunoglobulin Gen
dc.subjectvirus antibodyen
dc.subjectvirus antigenen
dc.subjectadulten
dc.subjectageden
dc.subjectantibody responseen
dc.subjectantigen specificityen
dc.subjectArticleen
dc.subjectclinical featureen
dc.subjectcomparative studyen
dc.subjectcontrolled studyen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectHuman cytomegalovirusen
dc.subjectimmune responseen
dc.subjectimmunoblottingen
dc.subjectimmunopathogenesisen
dc.subjectlow drug doseen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmultiple sclerosisen
dc.subjectpriority journalen
dc.subjectsteroid therapyen
dc.subjectsystemic sclerosisen
dc.subjectantibody specificityen
dc.subjectblooden
dc.subjectcase control studyen
dc.subjectCytomegalovirusen
dc.subjectimmunologyen
dc.subjectmiddle ageden
dc.subjectmultiple sclerosisen
dc.subjectsystemic sclerosisen
dc.subjectvery elderlyen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAntibodies, Viralen
dc.subjectAntibody Specificityen
dc.subjectAntigens, Viralen
dc.subjectCase-Control Studiesen
dc.subjectCytomegalovirusen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectImmunodominant Epitopesen
dc.subjectImmunoglobulin Gen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectMultiple Sclerosisen
dc.subjectScleroderma, Systemicen
dc.subjectAcademic Press Inc.en
dc.titleA comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosisen
dc.typejournalArticleen


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem